Edition:
India

MannKind Corp (MNKD.OQ)

MNKD.OQ on NASDAQ Stock Exchange Global Market

3.04USD
23 Feb 2018
Change (% chg)

$0.06 (+2.01%)
Prev Close
$2.98
Open
$3.06
Day's High
$3.13
Day's Low
$2.99
Volume
516,414
Avg. Vol
906,453
52-wk High
$6.96
52-wk Low
$0.67

Select another date:

Tue, Feb 6 2018

BRIEF-David Kendall Joins MannKind As Chief Medical Officer

* MANNKIND CORP - MOST RECENTLY, KENDALL SERVED AS RESEARCH PHYSICIAN AND VICE PRESIDENT OF GLOBAL MEDICAL AFFAIRS FOR LILLY DIABETES​ Source text for Eikon: Further company coverage:

BRIEF-Mannkind, On Jan 18, Co, Unit Entered Into Exchange, Sixth Amendment To Facility Agreement With Deerfield

* MANNKIND - ‍ ON JAN 18, CO AND UNIT ENTERED INTO AN EXCHANGE AND SIXTH AMENDMENT TO FACILITY AGREEMENT WITH DEERFIELD - SEC FILING​

BRIEF-Mannkind Q3 loss per share $0.31

* Mannkind Corporation reports 2017 third quarter financial results

BRIEF-Mannkind restructures near-term debt obligations

* Mannkind Corp - ‍extended maturity of $10 million of deerfield facility to Jan 15, 2018 and allowed for such principal to be converted into common stock​

BRIEF-Mannkind and Biomm submit registration dossier to Brazilian Health Regulatory Agency (anvisa)

* Mannkind and Biomm submit registration dossier to Brazilian Health Regulatory Agency (anvisa)

Select another date: